Life Sciences Corporate Partnering and Licensing
#1 Globally for Pharma and Biotech Licensing Deals
Why Cooley
-
40+ professionals across the US, UK and Asia exclusively focused on corporate partnering, licensing and other commercial transactions specific to life sciences companies
-
Decades of experience across a range of transaction structures, territories, product stages and technologies
-
Many in the group are backed by a wealth of supporting experience, having been in-house counsel at biotech or major pharmaceutical companies, business consultants and biotech researchers at life sciences companies
-
42% of the attorneys in our corporate partnering group have earned a bachelor’s degree with a life sciences focus, 30% a Master’s degree and 19% a PhD
-
Well-versed in the business, regulatory and commercial issues inherent in transactions, with the ability to call on a team of intellectual property, regulatory, reimbursement, tax, antitrust and other specialists as needed
-
Essentially, we serve as outsourced business advisors for many of our clients
-
Actively represent 1,900+ public and private life science company clients worldwide
Life Sciences & Healthcare Innovation Hub
Comprehensive resource for key stakeholders across the global life sciences and healthcare industry
Cooley Rx
A virtual series focused on the life sciences and healthcare sectors
Recognition
- LMG Life Sciences: 2022 Licensing & Collaboration Firm of the Year and 2021 Life Sciences Corporate Firm of the Year
- Chambers USA: Band 1 for Life Sciences
- Legal 500 US: Tier 1 for Healthcare: Life Sciences in 2021
- The Deal: 2021 Healthcare, Pharma & Biotech Law Firm & Deal of the Year (Large Cap)
- The Best Lawyers in America: 2019 Biotechnology Law Firm of the Year